Merck (MRK) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Merck (MRK) over the last 10 years. The current PE ratio for Merck as of August 21, 2017 is 16.10.
|Medical||Large Cap Pharmaceutical||$169.498B||$39.807B|
|Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.|